New bone graft material under scrutiny in 1,000-Patient spine study
NCT ID NCT06971835
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 1,000 people who received a bone graft material called Natural Matrix Protein (NMP) during spine surgery for degenerative disc disease. Researchers will monitor bone fusion, pain, and disability over two years to see if NMP is safe and helps the spine heal. Participants are already receiving NMP as part of their standard care, and this registry simply observes their outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Natural Matrix Protein (NMP) fibers and micro particulates, a bone graft material
- What this could lead to
- If successful, this could confirm that NMP is a safe and effective option to help bones fuse in spine surgery, potentially improving pain and disability outcomes.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may be less reliable. It is also early-stage evidence for a product already in use, and individual results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE (DDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Spine Center of Louisiana
Baton Rouge, Louisiana, 70809, United States
-
Spine Institute of Louisiana
Shreveport, Louisiana, 71101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pronged surgical approach beat standard surgery for neck pain?
- Spine surgery devices under the microscope: do they really work?
- Spine device study ends early with only 4 patients
- Back pain breakthrough? study pits two key surgeries against each other
- Injectable hydrogel could ease back pain without surgery
- Could stem cells ease stubborn back pain? new trial tests injection therapy